ResMed Results Top Estimate

(RTTNews) - ResMed Inc (RMD), a maker of medical equipment to treat respiratory disorders, on Thursday reported second-quarter net earnings of $91 million or $0.64 per share compared with $86.6 million or $0.60 per share last year.

Revenues for the quarter were $423 million compared with $384.3 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $0.62 per share on revenues of $405 million for the quarter. Analysts' estimates typically exclude special items.

"We are pleased to report strong double-digit revenue growth, demonstrating excellent progress with our new product launches," said Mick Farrell, ResMed's chief executive officer. "We achieved robust commercial performance across all regions, including double-digit growth in the Americas."

The company has declared a quarterly dividend of $0.28 per share.

ResMed develops medical equipment for the treatment of respiratory disorders, with a focus on sleep-disordered breathing.